The Valley Desk

NCT00831597 · Interventional trial

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Overall registry status Completed

Phase 2

Conditions Diffuse Large B-Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov